Novartis

Results: 1795



#Item
21ACT 3 NOVARTIS GLOBAL RESEARCH You may collect the meta puzzle at Location L after solving at least seven puzzles. Please check in at Location L by 4 pm regardless of how many puzzles you’ve solved. Page C1

ACT 3 NOVARTIS GLOBAL RESEARCH You may collect the meta puzzle at Location L after solving at least seven puzzles. Please check in at Location L by 4 pm regardless of how many puzzles you’ve solved. Page C1

Add to Reading List

Source URL: www.baphl.org

Language: English - Date: 2013-10-26 21:29:32
    22Dárci 2010 Finanční dary SAZKA Praha ROCHE Praha Pfizer s.r.o. Praha Novartis s.r.o., Praha

    Dárci 2010 Finanční dary SAZKA Praha ROCHE Praha Pfizer s.r.o. Praha Novartis s.r.o., Praha

    Add to Reading List

    Source URL: nadace.kostnidren.cz

    Language: Czech - Date: 2014-07-25 02:13:54
      23Novartis Pharmaceuticals Leveraging Big Data to Improve Outcomes in Healthcare Melvin “Skip” Olson, PhD Erlangen, 22nd February 2018

      Novartis Pharmaceuticals Leveraging Big Data to Improve Outcomes in Healthcare Melvin “Skip” Olson, PhD Erlangen, 22nd February 2018

      Add to Reading List

      Source URL: eit-health.de

      - Date: 2018-03-02 06:45:34
        24Joseph Jimenez Chief Executive Officer of Novartis Joseph Jimenez has been Chief Executive Officer (CEO) of Novartis sinceUnder his leadership, and driven by a commitment to R&D investment, Novartis has developed

        Joseph Jimenez Chief Executive Officer of Novartis Joseph Jimenez has been Chief Executive Officer (CEO) of Novartis sinceUnder his leadership, and driven by a commitment to R&D investment, Novartis has developed

        Add to Reading List

        Source URL: www.novartis.com

        - Date: 2016-09-23 08:45:35
          25Novartis International AG Novartis Global Communications CH-4002 Basel Switzerland http://www.novartis.com

          Novartis International AG Novartis Global Communications CH-4002 Basel Switzerland http://www.novartis.com

          Add to Reading List

          Source URL: hugin.info

          - Date: 2016-12-08 14:26:00
            26Building on its heritage of more than 65 years, Alcon, the global leader in eye care, is the second largest division of the Novartis Group with revenue of USD 10.8 billion inThe division was formed by Novartis on

            Building on its heritage of more than 65 years, Alcon, the global leader in eye care, is the second largest division of the Novartis Group with revenue of USD 10.8 billion inThe division was formed by Novartis on

            Add to Reading List

            Source URL: www2.unine.ch

            - Date: 2016-07-27 09:13:21
              27Novartis Pharmaceuticals Corporation One Health Plaza East Hanover, NJhttp://www.us.novartis.com MEDIA RELEASE • MEDIA RELEASE • MEDIA RELEASE

              Novartis Pharmaceuticals Corporation One Health Plaza East Hanover, NJhttp://www.us.novartis.com MEDIA RELEASE • MEDIA RELEASE • MEDIA RELEASE

              Add to Reading List

              Source URL: ueggb0yyjm0200i4-wpengine.netdna-ssl.com

              - Date: 2016-04-14 14:17:15
                28Studiengruppe für Gesundheitsschutz in Industrie, Dienstleistung und Gewerbe – www.sgig.ch Präsident: Hansueli Amsler, Novartis Pharma AG, Lichtstrasse 35, WSJ, 4002 Basel Sekretär: Heinz Frech, Höhenweg 2,

                Studiengruppe für Gesundheitsschutz in Industrie, Dienstleistung und Gewerbe – www.sgig.ch Präsident: Hansueli Amsler, Novartis Pharma AG, Lichtstrasse 35, WSJ, 4002 Basel Sekretär: Heinz Frech, Höhenweg 2,

                Add to Reading List

                Source URL: www.sgig.ch

                - Date: 2015-12-04 05:46:52
                  29June 24, 2016 **DCAT Sharp Sourcing Early Bird Rate Ends Today!** 1. Sandoz Progresses $1 Billion Biomanufacturing Plan for Biosimilars Sandoz, a Novartis division, plans to launch five biosimilars of major

                  June 24, 2016 **DCAT Sharp Sourcing Early Bird Rate Ends Today!** 1. Sandoz Progresses $1 Billion Biomanufacturing Plan for Biosimilars Sandoz, a Novartis division, plans to launch five biosimilars of major

                  Add to Reading List

                  Source URL: www.dcat.org

                  - Date: 2016-06-27 10:30:31
                    30Polityka antykorupcyjna Globalna polityka Novartis 1 marca 2012 r. Wersja GIC 100.V1.PL 1.

                    Polityka antykorupcyjna Globalna polityka Novartis 1 marca 2012 r. Wersja GIC 100.V1.PL 1.

                    Add to Reading List

                    Source URL: www.novartis.pl

                    - Date: 2016-05-04 06:19:45